Zealand Pharma A/S | ZEAL - Pre Tax Profit

Stock Price
290.50
Daily Change
-5.10 -1.73%
Monthly
11.86%
Yearly
-32.27%
Q2 Forecast
282.71

Zealand Pharma A/S reported -406.5M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025